Year,Market Value,Currency,Source,Notes
2021,4.5,EUR B,Allianz,Historic baseline (GLP-1 sales)
2023,21.2,EUR B,Allianz,GLP-1 sales doubled since 2021
2024,30+,USD B,IQVIA,Global obesity/GLP-1 market by 2024
2029,60,USD B,IQVIA / PBMI,Spending projection
2030,100–130,USD B,Goldman Sachs / JPMorgan,Aggressive forecast
2034,130,USD B,IQVIA,Long-term projection (13–15% CAGR)
